Search for: "Olympus Medical System Corp"
Results 1 - 9
of 9
Sorted by Relevance
|
Sort by Date
29 Oct 2015, 7:47 am
The Washington Post “To Your Health” reports that the Food and Drug Administration on Monday ordered duodenoscope makers Olympus America, Fujifilm Medical Systems and Hoya Corp to “conduct real-world evaluations on how well health care workers are cleaning and disinfecting the devices. [read post]
12 Jul 2016, 7:45 am
The Denver Post reported that nine patients treated at the University of Colorado Hospital “patients developed infections, and three of them later died, after undergoing” endoscopic retrograde cholangiopancreatography procedures with an “Olympus Medical System Corp. duodenoscope,” a device “suspected of causing fatal infections nationally. [read post]
31 Aug 2015, 4:25 am
The procedures were carried out with a duodenoscope made by Japan’s Olympus Medical System Corp. and sold and marketed by Olympus Medical System Corp. and Olympus Corp. of the Americas. [read post]
15 Jul 2011, 11:45 am
The parties did not disclose the terms of the sale of Spirus Medical Inc., of West Bridgewater, to Olympus Corp. of Japan. [read post]
6 Mar 2016, 9:11 am
The penalties against Olympus Corp. of Japan were the largest ever levied under U.S. anti-kickback laws. [read post]
10 Mar 2016, 7:47 am
” It also called on Congress to mandate that insurance claims include “unique device identifiers” and fund a national medical device evaluation system so the FDA can “effectively monitor the safety of medical devices on the market rather than relying on adverse event reporting. [read post]
15 Dec 2010, 10:56 am
Patent No. 5,996,011 entitled SYSTEM AND METHOD FOR FILTERING DATA RECEIVED BY A COMPUTER SYSTEM and owned by Symantec Corp. [read post]
15 Dec 2010, 10:56 am
Patent No. 5,996,011 entitled SYSTEM AND METHOD FOR FILTERING DATA RECEIVED BY A COMPUTER SYSTEM and owned by Symantec Corp. [read post]
28 Apr 2008, 11:00 am
: (Patent Docs), US: Supreme Court declines to hear final Nucleonics’ appeal in gene-silencing patent dispute with Benitec Australia: (IP Law360), (Therapeutics Daily), US: 505(b)(2) drug approvals rock - Interaction of patents and exclusivity of drugs approved by FDA under section 505(b)(2): (Patent Baristas), US: StemCells’ patents survive reexam – StemCells and Neuralstem differ on extent of changes: (Patent Docs), US: StemCells announces issuance of… [read post]
